Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
6.52
-0.45 (-6.46%)
At close: Mar 20, 2026, 4:00 PM EDT
6.48
-0.04 (-0.65%)
After-hours: Mar 20, 2026, 6:58 PM EDT
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $13.53 million as of March 20, 2026. Its market cap has decreased by -54.53% in one year.
Market Cap
13.53M
Enterprise Value
9.67M
1-Year Change
-54.53%
Ranking
Category
Stock Price
$6.52
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $13.53M, a decrease of -76.73%. That is a compound annual growth rate of -36.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 15.24M | -3.83% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intensity Therapeutics | 16.04M |
| AEON Biopharma | 15.59M |
| Artelo Biosciences | 15.21M |
| Cocrystal Pharma | 15.02M |
| Hoth Therapeutics | 14.33M |
| Phio Pharmaceuticals | 13.71M |
| IO Biotech | 13.67M |
| Cellectar Biosciences | 13.48M |